Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Dan H. Moore's publication output changed over time?
ScholarIQpublication output · 1942–2012
Output grew100% over the shown period — from 1 works in 1942 to 2 in 2012.
1
1
3
1
2
1
2
1942195719922002200620072012
What are the most-cited papers on Dan H. Moore?
ScholarIQmost cited works
Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
Noel Weidner, J Folkman, F. Pozza, Pierantonio Bevilacqua, Elizabeth N. Allred, Dan H. Moore, S Meli, Giampietro Gasparini
JNCI Journal of the National Cancer Institute. 19921,797 Citations
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Robert G. Miller, John D. Mitchell, Dan H. Moore
Cochrane Database of Systematic Reviews. 20121,054 CitationsOPEN ACCESS
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers
Ann D. Thor, Dan H. Moore, S M Edgerton, Ernest S. Kawasaki, Ellen Reihsaus, Henry T. Lynch, Joseph Marcus, L. Schwartz, L.-C. Chen, Brian H. Mayall, Helene S. Smith
JNCI Journal of the National Cancer Institute. 1992733 Citations
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, José Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan H. Moore, Demetrios Papahadjopoulos, Christopher C. Benz
PubMed. 2002648 CitationsOPEN ACCESS
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan
S70053155. 2007642 Citations
Related on ScholarIQ
Lawrence Livermore National Laboratory
Institution
Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
Paper
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Paper
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers
Paper
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Paper
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paper